Section Arrow
Quote
VRAX.NASDAQ
- Virax Biolabs Group Limited
(Financial Status)
Quotes are at least 15-min delayed:2026/01/06 20:34 EST
Regular Hours
Last
 0.4213
+0.0376 (+9.80%)
Day High 
0.4384 
Prev. Close
0.3837 
1-M High
0.6234 
Volume 
478.85K 
Bid
0.395
Ask
0.41
Day Low
0.4081 
Open
0.4084 
1-M Low
0.31 
Market Cap 
2.85M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.36 
20-SMA 0.41 
50-SMA 0.46 
52-W High 2.61 
52-W Low 0.31 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.22/-1.01
Enterprise Value
3.14M
Balance Sheet
Book Value Per Share
0.72
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
6.33K
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CYCNCyclerion Therapeutics1.95+0.57+41.30%-- 
ALMSAlumis Inc.16.23+7.92+95.31%0.33PE
MREOMereo BioPharma Group plc0.379-0.1016-21.14%-- 
SLSSELLAS Life Sciences Group4.1-0.9-18.00%-- 
RXRXRecursion Pharmaceuticals4.55+0.18+4.12%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and otherchronic conditions linked to immune dysregulation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.